Pharmaceutical

Class action lawsuit calls for advertising campaign to warn of ovarian cancer risks with baby powder

powder 3 435x326 Class action lawsuit calls for advertising campaign to warn of ovarian cancer risks with baby powder A class action lawsuit has been filed against consumer health care giant Johnson & Johnson alleging the company’s baby powder causes ovarian cancer. The lawsuit claims that Johnson & Johnson was aware of the risks but failed to warn consumers, instead marketing the product as safe.

The class action comes as many similar ovarian cancer lawsuits have been filed against Johnson & Johnson. The complaints allege that the company’s products contain talcum powder, derived from talc, which is a known carcinogen. When used for personal hygiene in the genital area, researchers have found that the talc can travel up the uterus, into the cervix, through the fallopian tubes and into the ovaries, where the powder can create a welcome environment for abnormal cell growth leading to cancer.

The first lawsuit to allege a link between Johnson & Johnson’s talcum products and ovarian cancer was filed by a woman from South Dakota. The jury found that the company should have taken measures to warn women of this risk. Even after the verdict was handed down, Johnson & Johnson said it did not think it was necessary to put an ovarian cancer warning on the labels of its talc-containing products.

The class action lawsuit consists of all Missouri residents within the past five years who have bought Johnson & Johnson’s baby powder. Plaintiffs are seeking punitive damages and a corrective advertising campaign to fully warn consumers of the ovarian cancer risks connected with using the company’s talc-containing products in their genital area.

Attorneys with Beasley Allen Law Firm are currently investigating cases of ovarian cancer in women who have used talcum powder products for personal hygiene.

Source: Lexology